Researchers from the Memorial Sloan-Kettering Cancer Center in New York have published findings in the journal Cell that explain how tumor cells can re-seed and spread throughout the body after they have been removed through conventional chemotherapy, surgery, or radiation treatments. Tiny tumor cells that circulate throughout the body often begin to send out seeds to the places where the tumor originated, essentially planting the cancer back into the body.

Joan Massague and her colleagues at the Center are finding that conventional treatments leave behind malignant cells that relocate to other areas of the body to avoid being destroyed. Eventually they return as stronger and more aggressive tumors, having gathered back the worst leftover cells from the previous cancer. The result is a second cancer that is worse than the first.

Chemicals present in the immune system also appear to signal tumor cells in circulation to return to their source. Following conventional treatment, the immune system actually works against the body by drawing the vagrant cancer cells back to where they originally seeded, kick starting a relapse.

Medical professionals typically attribute recurrences of cancer following conventional treatment to a few remaining cells that survived treatment and remained at the source. However this study illustrates definitively that lingering cells hide throughout the body and later return to self seed back where they originally started.

What these findings illustrate is that conventional cancer treatments are not effective at eradicating cancer from the body. The targeting of a specific area with surgery, radiation treatment, and chemotherapy cannot successfully remove the cancer from the body because its cells will find another place to live temporarily, only to return even stronger the next time.

Biopsies cause cancer to spread

A conventional biopsy is usually recommended as the best way to identify the presence of cancer, both before and after treatments. Needle biopsies involve taking tissue samples at various places in order to identify the presence of cancer cells. Official diagnosis of cancer cannot take place without a biopsy, resulting in the pressuring of patients to get one if they suspect a tumor.

Many doctors will insist that a person needs a biopsy, but the threat of spreading cancer far outweighs any perceived benefits. Those who receive biopsies will most likely experience unnecessary cancer spread and, following conventional treatment, will probably experience cancer reseeding. Cancer is known to develop at the puncture sites of biopsies.

Chemotherapy leads to reseeding

Chemotherapy treatments involve targeting cancer cells that are rapidly dividing and spreading with harsh chemicals designed to kill them. While treatment may kill the primary tumor, it fails to eradicate the cells that divide more slowly, resulting in a continued replication of cancer cells following treatment.

Many who believe they are in remission following their chemotherapy treatments later discover that their cancer has returned. Not only do they undergo the horrors of the treatment which leaves their body and health in shambles, but they often end up with a more severe version of their original cancer.

Conventional therapies are a failure

Conventional medicine is at a loss for how to deal with the problem of reseeding. Within their paradigm, chemotherapy, radiation, drugs, and surgery are the only options for treating someone with cancer. Now that these are proving to be largely ineffective, scientists are searching for yet another new drug to combat the tendency of cancers to re-seed in order to continue promoting these accepted forms of cancer treatment. They are even investigating the possibility of developing vaccines that will allegedly use the body’s immune system to stop vagrant cancer cells.

The problem with drugs, surgery, and radiation is that they will never be able to systematically rid the body of the problem because they are only capable of targeting a confined area. These methods are also wrought with negative side effects so severe that many people end up dying simply from the treatment.

Conventional treatment is also extremely expensive, heavily burdening an already overwhelmed health care system. It is simply assumed that there are no alternative methods by which cancer can be treated, let alone prevented.

Many recently published studies have found that pomegranates, mangoes, and other natural foods contain valuable phytonutrients that effectively prevent and stop malignant cancer cells while preserving good cells. These nutrients holistically rid the body of harmful cells, targeting them wherever they hide in the body and eliminating them.

Conventional medicine would do best to begin focusing heavily on the compounds found in nature that are designed to deter cancer without inflicting negative side effects as an alternative to the mainstream methods that are only making the problem worse. Whether in aloe vera, peach pits, raw almonds, or the many fruits and vegetables found around the world, anti-cancer nutrients are everywhere and modern medicine is only beginning to recognize them. They may not result in the next big blockbuster drug but they work and they are inexpensive. Perhaps this is the reason they are generally marginalized and looked down upon by the cancer industry.

by : Ethan A. Huff from Naturalnews

Sources for this story include:

http://www.reuters.com/article/idUS…

http://www.ethiopianreview.com/news…

http://www.healingcancernaturally.c…

Broken Links ? Questions ?

TO CONTACT JMB CLICK ON THE STAMP

FDA Required Disclosure

jmbblog

A podcast powered by FeedBurner

Send article as PDF to

After a two year visit to the United States , Michelangelo’s David

is returning to Italy ….

His proud sponsors in the USA were:

Mc Donald, Burger King, Pizza Hut, KFC,

USDA, FDA, American Medical Association…

Broken Links ? Questions ?

TO CONTACT JMB CLICK ON THE STAMP

FDA Required Disclosure

jmbblog

A podcast powered by FeedBurner

Send article as PDF to

Cancer Cure – Cannabis & Cannabinoids,by Robert Melamede,PhD

URL : http://www.youtube.com/watch?v=n31Nuj_AvTg

Robert Melamede is an associate professor of biology at the University of Colorado, in one of the 11 states that allow the medicinal use of marijuana.

Dr. Melamede is an expert on the biology of the cannabis plant, how it relates to the human endocannabinoid system, and why the cannabis plant has the potential to affect so many diseases and illnesses.

Dr. Robert Melamede received his Ph.D. from the City University of New York. From there he became a Research Associate and Research Assistant Professor at New York Medical College. In 1989 he became a Research Assistant Professor at the University of Vermont. In 2001 he moved to the University of Colorado at Colorado Springs as an Associate Professor, and became the Chairman of the Biology Department until he retired as Chairman in the Fall of 2005.

Dr. Melamede’s expertise has been the repair of DNA damages caused by free radicals, the production of monoclonal antibodies via phage display, far from equilibrium thermodynamics as applied to biological systems, and pulling these all together, the endocannabinoid system. Additional, Dr. Melamede is a founder of a small biotech company (Newellink) exploring novel cancer therapies.

Broken Links ? Questions ?

TO CONTACT JMB CLICK ON THE STAMP

FDA Required Disclosure

jmbblog

A podcast powered by FeedBurner

Send article as PDF to

May Set Stage for Treating Brain Damage in People

PHILADELPHIA, Dec. 8 /PRNewswire-USNewswire/ — Neurology researchers have shown that feeding amino acids to brain-injured animals restores their cognitive abilities and may set the stage for the first effective treatment for cognitive impairments suffered by people with traumatic brain injuries.

“We have shown in an animal model that dietary intervention can restore a proper balance of neurochemicals in the injured part of the brain, and simultaneously improves cognitive performance,” said study leader Akiva S. Cohen, Ph.D., a neuroscientist at The Children’s Hospital of Philadelphia.

The study appeared Dec. 7 in the online issue of the Proceedings of the National Academy of Sciences.

If these results in mice can be translated to human medicine, there would be a broad clinical benefit. Every 23 seconds, a man, woman or child in the United States suffers a traumatic brain injury (TBI). The primary cause of death and disability in children and young adults, TBI also accounts for permanent disabilities in more than 5 million Americans. The majority of those cases are from motor vehicle injuries, along with a rising incidence of battlefield casualties.

Although physicians can relieve the dangerous swelling that occurs after a TBI, there are currently no treatments for the underlying brain damage that brings in its wake cognitive losses in memory, learning and other functions.

The animals in the current study received a cocktail of three branched chain amino acids (BCAAs), specifically leucine, isoleucine and valine, in their drinking water. Previous researchers had shown that people with severe brain injuries showed mild functional improvements after receiving BCAAs through an intravenous line.

BCAAs are crucial precursors of two neurotransmitters — glutamate and gamma-aminobutyric acid, or GABA, which function together to maintain an appropriate balance of brain activity. Glutamate excites neurons, stimulating them to fire, while GABA inhibits the firing. Too much excitement or, too little, and the brain doesn’t work properly. A TBI upsets the balance.

Read more ..

CONTACT: John Ascenzi of The Children’s Hospital of Philadelphia, +1-267-426-6055, Ascenzi@email.chop.edu

Leucine is one of the building blocks of protein, particularly from animal foods, and it can be consumed through meat, dairy, soy, beans and other protein-rich sources. It’s also widely sold as a dietary supplement. You can purchase a combination of leucine, isoleucine and valine branched chain amino acids by visiting BCAA supplement

Broken Links ? Questions ?

TO CONTACT JMB CLICK ON THE STAMP

FDA Required Disclosure

jmbblog

A podcast powered by FeedBurner

Send article as PDF to